William Sutherland
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Metal complexes synthesis and properties
- Pancreatic and Hepatic Oncology Research
- Cancer Treatment and Pharmacology
Papers in
- Oncology 8
- Cancer Treatment and Pharmacology 3
- Colorectal Cancer Treatments and Studies 2
- PARP inhibition in cancer therapy 1
- Lung Cancer Research Studies 1
- Pancreatic and Hepatic Oncology Research 1
-
- Radiation Therapy and Dosimetry 1
- Co-authors
- Esteban Cvitkovic (4 shared papers)Ernesto Wasserman (4 shared papers)J.L. Misset (1 shared paper)Mohamed Békradda (1 shared paper)Harry Bleiberg (1 shared paper)Peter J. Rosen (2 shared papers)David Loesch (2 shared papers)Daniel D. Von Hoff (3 shared papers)
- Journals
- Molecular Cancer Therapeutics (2 papers)Journal of Clinical Oncology (2 papers)Clinical Cancer Research (1 paper)Critical Reviews in Oncology/Hematology (1 paper)Cancer Treatment Reviews (1 paper)
- Partner nations
- United StatesFranceBelgium
In The Last Decade
William Sutherland
11 papers receiving 694 citations
Peers
Comparison fields: 5 of 71
- Cancer Research 248
- Oncology 293
- Pulmonary and Respiratory Medicine 148
- Pathology and Forensic Medicine 68
- Statistics and Probability 32
Countries citing papers authored by William Sutherland
This map shows the geographic impact of William Sutherland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Sutherland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Sutherland more than expected).
Fields of papers citing papers by William Sutherland
This network shows the impact of papers produced by William Sutherland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Sutherland. The network helps show where William Sutherland may publish in the future.
Co-authors
The 25 scholars most cited alongside William Sutherland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 465 | |
| 2 | 2000 | 159 | |
| 3 | 2009 | 34 | |
| 4 | 2001 | 25 | |
| 5 | 2004 | 14 | |
| 6 | 2011 | 3 | |
| 7 | 1964 | 3 | |
| 8 | 1998 | 2 | |
| 9 | Pharmacokinetics of a nucleoside analogue CP-4055 in two phase I trials using a daily for 5 days schedule and three intermittent weekly or biweekly schedules | 2005 | 2 |
| 10 | 1974 | 1 | |
| 11 | 2009 | 1 |
About William Sutherland
William Sutherland is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Infectious Diseases and Organic Chemistry, having authored 11 papers that have together received 709 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (3 papers), Cancer Genomics and Diagnostics (2 papers), Colorectal Cancer Treatments and Studies (2 papers), PARP inhibition in cancer therapy (1 paper), Click Chemistry and Applications (1 paper), Lung Cancer Research Studies (1 paper), Radiation Therapy and Dosimetry (1 paper) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Cancer Research (248 citations), Oncology (293 citations), Pulmonary and Respiratory Medicine (148 citations), Pathology and Forensic Medicine (68 citations) and Statistics and Probability (32 citations). William Sutherland has collaborated with scholars based in United States, France and Belgium. Frequent co-authors include Esteban Cvitkovic, Ernesto Wasserman, J.L. Misset, Mohamed Békradda, Harry Bleiberg, Peter J. Rosen, David Loesch, Daniel D. Von Hoff, Mitesh J. Borad and Cristian Fernández. Their work appears in journals such as Molecular Cancer Therapeutics, Journal of Clinical Oncology, Clinical Cancer Research, Critical Reviews in Oncology/Hematology and Cancer Treatment Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.